Predictive factors of response to phase I complete decongestive therapy in upper extremity lymphedema following breast carcinoma in Iran.
Identifieur interne : 003280 ( Main/Exploration ); précédent : 003279; suivant : 003281Predictive factors of response to phase I complete decongestive therapy in upper extremity lymphedema following breast carcinoma in Iran.
Auteurs : S. Haghighat [Iran] ; M. Lotfi-Tokaldany [Iran] ; A A Khadem Maboudi [Iran] ; M. Karami [Iran] ; A. Bahadori [Iran] ; J. Weiss [États-Unis]Source :
- Lymphology [ 0024-7766 ] ; 2013.
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- MESH :
- geographic : Iran.
- etiology : Lymphedema.
- surgery : Breast Neoplasms.
- therapy : Lymphedema.
- Adult, Aged, Aged, 80 and over, Bandages, Clothing, Drainage, Female, Humans, Massage, Mastectomy, Middle Aged, Treatment Outcome, Upper Extremity.
Abstract
Post-mastectomy chronic lymphedema as a complication of breast cancer treatment is primarily managed with Complete Decongestive Therapy (CDT). We examined various factors for correlating with results of Phase I CDT treatment in controlling the upper extremity lymphedema. Study population consisted of patients with lymphedema referred to the Lymphedema Clinic of the Iranian Breast Cancer Research Center for control of arm edema. After obtaining the demographic and clinical data, patients were treated with CDT for 2 - 3 weeks. One hundred and thirty seven patients (mean age +/- SD; 53.5 +/- 10 years) were studied. In 48.7% of patients, the affected arm was the dominant limb. Fifty percent of patients experienced lymphedema during the first year after surgery, and mean duration of lymphedema was 35 +/- 43 months. Mean volume reduction was 43% +/- 14.87% (p = 0.03). There was a significant relationship between the percent of volume reduction and initial lymphedema volume (p=0.003) as well as duration of lymphedema (p=0.002). Our results demonstrate that Phase I CDT treatment is very effective for post mastectomy lymphedema, and particularly if it is provided in earlier stages of disease. In addition, CDT also has an important role in reducing clinical symptoms and improving limb function. In the appropriate setting, Phase I CDT has been an effective method of controlling post mastectomy lymphedema in this Iranian population.
PubMed: 24354108
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001768
- to stream PubMed, to step Curation: 001768
- to stream PubMed, to step Checkpoint: 001768
- to stream Ncbi, to step Merge: 006081
- to stream Ncbi, to step Curation: 006081
- to stream Ncbi, to step Checkpoint: 006081
- to stream Main, to step Merge: 003285
- to stream Main, to step Curation: 003280
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Predictive factors of response to phase I complete decongestive therapy in upper extremity lymphedema following breast carcinoma in Iran.</title><author><name sortKey="Haghighat, S" sort="Haghighat, S" uniqKey="Haghighat S" first="S" last="Haghighat">S. Haghighat</name><affiliation wicri:level="1"><nlm:affiliation>Quality of Life in Cancer Department, Iranian Breast Cancer Research Center, ACECR, Tehran, Iran. Sha_haghighat@yahoo.com</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Quality of Life in Cancer Department, Iranian Breast Cancer Research Center, ACECR, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Lotfi Tokaldany, M" sort="Lotfi Tokaldany, M" uniqKey="Lotfi Tokaldany M" first="M" last="Lotfi-Tokaldany">M. Lotfi-Tokaldany</name><affiliation wicri:level="1"><nlm:affiliation>Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Maboudi, A A Khadem" sort="Maboudi, A A Khadem" uniqKey="Maboudi A" first="A A Khadem" last="Maboudi">A A Khadem Maboudi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Biostatistics, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Biostatistics, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Karami, M" sort="Karami, M" uniqKey="Karami M" first="M" last="Karami">M. Karami</name><affiliation wicri:level="1"><nlm:affiliation>Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Bahadori, A" sort="Bahadori, A" uniqKey="Bahadori A" first="A" last="Bahadori">A. Bahadori</name><affiliation wicri:level="1"><nlm:affiliation>Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Weiss, J" sort="Weiss, J" uniqKey="Weiss J" first="J" last="Weiss">J. Weiss</name><affiliation wicri:level="2"><nlm:affiliation>Cox Health, Springfield, MO, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Cox Health, Springfield, MO</wicri:regionArea><placeName><region type="state">Missouri (État)</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:24354108</idno><idno type="pmid">24354108</idno><idno type="wicri:Area/PubMed/Corpus">001768</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001768</idno><idno type="wicri:Area/PubMed/Curation">001768</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001768</idno><idno type="wicri:Area/PubMed/Checkpoint">001768</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001768</idno><idno type="wicri:Area/Ncbi/Merge">006081</idno><idno type="wicri:Area/Ncbi/Curation">006081</idno><idno type="wicri:Area/Ncbi/Checkpoint">006081</idno><idno type="wicri:doubleKey">0024-7766:2013:Haghighat S:predictive:factors:of</idno><idno type="wicri:Area/Main/Merge">003285</idno><idno type="wicri:Area/Main/Curation">003280</idno><idno type="wicri:Area/Main/Exploration">003280</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Predictive factors of response to phase I complete decongestive therapy in upper extremity lymphedema following breast carcinoma in Iran.</title><author><name sortKey="Haghighat, S" sort="Haghighat, S" uniqKey="Haghighat S" first="S" last="Haghighat">S. Haghighat</name><affiliation wicri:level="1"><nlm:affiliation>Quality of Life in Cancer Department, Iranian Breast Cancer Research Center, ACECR, Tehran, Iran. Sha_haghighat@yahoo.com</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Quality of Life in Cancer Department, Iranian Breast Cancer Research Center, ACECR, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Lotfi Tokaldany, M" sort="Lotfi Tokaldany, M" uniqKey="Lotfi Tokaldany M" first="M" last="Lotfi-Tokaldany">M. Lotfi-Tokaldany</name><affiliation wicri:level="1"><nlm:affiliation>Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Maboudi, A A Khadem" sort="Maboudi, A A Khadem" uniqKey="Maboudi A" first="A A Khadem" last="Maboudi">A A Khadem Maboudi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Biostatistics, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Biostatistics, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Karami, M" sort="Karami, M" uniqKey="Karami M" first="M" last="Karami">M. Karami</name><affiliation wicri:level="1"><nlm:affiliation>Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Bahadori, A" sort="Bahadori, A" uniqKey="Bahadori A" first="A" last="Bahadori">A. Bahadori</name><affiliation wicri:level="1"><nlm:affiliation>Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Weiss, J" sort="Weiss, J" uniqKey="Weiss J" first="J" last="Weiss">J. Weiss</name><affiliation wicri:level="2"><nlm:affiliation>Cox Health, Springfield, MO, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Cox Health, Springfield, MO</wicri:regionArea><placeName><region type="state">Missouri (État)</region></placeName></affiliation></author></analytic><series><title level="j">Lymphology</title><idno type="ISSN">0024-7766</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Bandages</term><term>Breast Neoplasms (surgery)</term><term>Clothing</term><term>Drainage</term><term>Female</term><term>Humans</term><term>Iran</term><term>Lymphedema (etiology)</term><term>Lymphedema (therapy)</term><term>Massage</term><term>Mastectomy</term><term>Middle Aged</term><term>Treatment Outcome</term><term>Upper Extremity</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Bandages</term><term>Drainage</term><term>Femelle</term><term>Humains</term><term>Iran</term><term>Lymphoedème ()</term><term>Lymphoedème (étiologie)</term><term>Massage</term><term>Mastectomie</term><term>Membre supérieur</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Tumeurs du sein ()</term><term>Vêtements</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Iran</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Bandages</term><term>Clothing</term><term>Drainage</term><term>Female</term><term>Humans</term><term>Massage</term><term>Mastectomy</term><term>Middle Aged</term><term>Treatment Outcome</term><term>Upper Extremity</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Bandages</term><term>Drainage</term><term>Femelle</term><term>Humains</term><term>Iran</term><term>Lymphoedème</term><term>Massage</term><term>Mastectomie</term><term>Membre supérieur</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Tumeurs du sein</term><term>Vêtements</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Post-mastectomy chronic lymphedema as a complication of breast cancer treatment is primarily managed with Complete Decongestive Therapy (CDT). We examined various factors for correlating with results of Phase I CDT treatment in controlling the upper extremity lymphedema. Study population consisted of patients with lymphedema referred to the Lymphedema Clinic of the Iranian Breast Cancer Research Center for control of arm edema. After obtaining the demographic and clinical data, patients were treated with CDT for 2 - 3 weeks. One hundred and thirty seven patients (mean age +/- SD; 53.5 +/- 10 years) were studied. In 48.7% of patients, the affected arm was the dominant limb. Fifty percent of patients experienced lymphedema during the first year after surgery, and mean duration of lymphedema was 35 +/- 43 months. Mean volume reduction was 43% +/- 14.87% (p = 0.03). There was a significant relationship between the percent of volume reduction and initial lymphedema volume (p=0.003) as well as duration of lymphedema (p=0.002). Our results demonstrate that Phase I CDT treatment is very effective for post mastectomy lymphedema, and particularly if it is provided in earlier stages of disease. In addition, CDT also has an important role in reducing clinical symptoms and improving limb function. In the appropriate setting, Phase I CDT has been an effective method of controlling post mastectomy lymphedema in this Iranian population.</div></front></TEI><affiliations><list><country><li>Iran</li><li>États-Unis</li></country><region><li>Missouri (État)</li></region></list><tree><country name="Iran"><noRegion><name sortKey="Haghighat, S" sort="Haghighat, S" uniqKey="Haghighat S" first="S" last="Haghighat">S. Haghighat</name></noRegion><name sortKey="Bahadori, A" sort="Bahadori, A" uniqKey="Bahadori A" first="A" last="Bahadori">A. Bahadori</name><name sortKey="Karami, M" sort="Karami, M" uniqKey="Karami M" first="M" last="Karami">M. Karami</name><name sortKey="Lotfi Tokaldany, M" sort="Lotfi Tokaldany, M" uniqKey="Lotfi Tokaldany M" first="M" last="Lotfi-Tokaldany">M. Lotfi-Tokaldany</name><name sortKey="Maboudi, A A Khadem" sort="Maboudi, A A Khadem" uniqKey="Maboudi A" first="A A Khadem" last="Maboudi">A A Khadem Maboudi</name></country><country name="États-Unis"><region name="Missouri (État)"><name sortKey="Weiss, J" sort="Weiss, J" uniqKey="Weiss J" first="J" last="Weiss">J. Weiss</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003280 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003280 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:24354108
|texte= Predictive factors of response to phase I complete decongestive therapy in upper extremity lymphedema following breast carcinoma in Iran.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24354108" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |